SIRT4 and central nervous system cancer: In a study related to gliomas, SIRT4 was shown to be lowly expressed in gliomas and to be less expressed with increasing tumor cell malignancy, survival analysis showed that patients with high SIRT4 expression had higher survival rates than those with low expression,19 and overexpression of SIRT4 had a protective effect on glial cell excitability.20